Position in TFX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,652,910
+$4,010,967 QoQ
Shares Held
84,040
+51.3% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#66
of 384 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TFX Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $221,060,137 across 12 Medical Instruments & Supplies names. TFX ranks #9 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVTR |
Avantor, Inc.
|
3,676,084 | $36,393,231 | |
| 2 | NVST |
Envista Holdings Corp
|
1,270,717 | $33,483,392 | |
| 3 | ANGO |
Angiodynamics Inc
|
1,969,835 | $25,627,553 | |
| 4 | RGEN |
Repligen Corp
|
174,794 | $23,848,893 | |
| 5 | AZTA |
Azenta, Inc.
|
891,419 | $22,749,012 | |
| 6 | BLFS |
Biolife Solutions Inc
|
623,875 | $17,618,230 | |
| 7 | STVN |
Stevanato Group S.p.A.
|
916,356 | $16,558,552 | |
| 8 | COO |
Cooper Companies, Inc.
|
223,879 | $16,054,363 |
All Filings in TFX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,652,910 | 84,040 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,641,943 | 55,530 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,231,341 | 92,030 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $8,565,200 | 70,000 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||